These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 10466077

  • 1. Modulating effects of sensory and autonomic neuropeptides on murine splenocyte proliferation and cytokine secretion induced by Leishmania major.
    Ahmed AA, Mutt V, Nordlind K.
    Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):507-26. PubMed ID: 10466077
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites.
    Ahmed AA, Wahbi AH, Nordlin K.
    Immunopharmacol Immunotoxicol; 2001 Aug; 23(3):397-409. PubMed ID: 11694030
    [Abstract] [Full Text] [Related]

  • 3. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
    Dallos A, Kiss M, Polyánka H, Dobozy A, Kemény L, Husz S.
    Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
    [Abstract] [Full Text] [Related]

  • 4. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides.
    Ahmed AA, Wahbi A, Nordlind K, Kharazmi A, Sundqvist KG, Mutt V, Lidén S.
    Scand J Immunol; 1998 Jul; 48(1):79-85. PubMed ID: 9714414
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.
    Boudard F, Bastide M.
    J Neurosci Res; 1991 May; 29(1):29-41. PubMed ID: 1653367
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets.
    Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H.
    Neuroimmunomodulation; 1998 May; 5(1-2):9-15. PubMed ID: 9698253
    [Abstract] [Full Text] [Related]

  • 7. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients.
    Kimata H, Yoshida A, Fujimoto M, Mikawa H.
    J Immunol; 1993 May 15; 150(10):4630-40. PubMed ID: 7683325
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells.
    Bjurholm A, Kreicbergs A, Schultzberg M, Lerner UH.
    J Bone Miner Res; 1992 Sep 15; 7(9):1011-9. PubMed ID: 1384276
    [Abstract] [Full Text] [Related]

  • 9. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements.
    Nio DA, Moylan RN, Roche JK.
    J Immunol; 1993 Jun 15; 150(12):5281-8. PubMed ID: 8515059
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G.
    Eur J Immunol; 1996 Jul 15; 26(7):1553-9. PubMed ID: 8766560
    [Abstract] [Full Text] [Related]

  • 13. Neuropeptides (SP and CGRP) augment pro-inflammatory cytokine production in HSV-infected macrophages.
    Yaraee R, Ebtekar M, Ahmadiani A, Sabahi F.
    Int Immunopharmacol; 2003 Dec 15; 3(13-14):1883-7. PubMed ID: 14636837
    [Abstract] [Full Text] [Related]

  • 14. Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries.
    Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J, Stiernholm P, Edvinsson L.
    Ann Neurol; 1986 Oct 15; 20(4):496-501. PubMed ID: 2431650
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.
    Stanisz AM, Befus D, Bienenstock J.
    J Immunol; 1986 Jan 15; 136(1):152-6. PubMed ID: 2415614
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 17. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.
    Adeghate E.
    Neuropeptides; 1999 Jun 01; 33(3):227-35. PubMed ID: 10657496
    [Abstract] [Full Text] [Related]

  • 18. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.
    J Immunol; 1998 Dec 01; 161(11):6171-9. PubMed ID: 9834103
    [Abstract] [Full Text] [Related]

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 20. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH, Morin P, Titus RG.
    Exp Parasitol; 1996 Nov 15; 84(2):136-43. PubMed ID: 8932763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.